Update in Women's Health
Authors: Karen M. Freund, Nancy C. Dolan, Heidi D. Nelson
Journal: Annals of Internal Medicine (2003)

Updates from the Annual Session21 January 2003Update in Women's HealthKaren M. Freund, MD, MPH, Nancy C. Dolan, MD, and Heidi D. Nelson, MD, MPHKaren M. Freund, MD, MPHFrom Boston University Medical Center, Boston, Massachusetts; Feinberg School of Medicine, Northwestern University Medical School, Chicago, Illinois; and Oregon Health & Science University, Portland, Oregon.Search for more papers by this author, Nancy C. Dolan, MDFrom Boston University Medical Center, Boston, Massachusetts; Feinberg School of Medicine, Northwestern University Medical School, Chicago, Illinois; and Oregon Health & Science University, Portland, Oregon.Search for more papers by this author, and Heidi D. Nelson, MD, MPHFrom Boston University Medical Center, Boston, Massachusetts; Feinberg School of Medicine, Northwestern University Medical School, Chicago, Illinois; and Oregon Health & Science University, Portland, Oregon.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-138-2-200301210-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In 2001, the significant themes in women's health focused again on the controversies in the care of women during the menopausal transition, including hormone therapy, the role of cancer screening tests, and the management of osteoporosis. In addition to these topics, important new information emerged on a breadth of health issues seen daily by general internists, such as physical activity counseling, partner violence, urinary tract infections, and contraception. This Update discusses reports published in 2001 selected through a systematic review of the major general medical journals, subspecialty journals in gynecology and women's health, and review publications such as ACP Journal ...References1. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-13. [PMID: 9718051] CrossrefMedlineGoogle Scholar2. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58:529-34. [PMID: 11386980] CrossrefMedlineGoogle Scholar3. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, . Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183:414-20. [PMID: 10942479] CrossrefMedlineGoogle Scholar4. Ferrara A, Karter AJ, Ackerson LM, Liu JY, Selby JV. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 2001;24:1144-50. [PMID: 11423493] CrossrefMedlineGoogle Scholar5. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344:1743-9. [PMID: 11396440] CrossrefMedlineGoogle Scholar6. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, . Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285:320-3. [PMID: 11176842] CrossrefMedlineGoogle Scholar7. Khan SA, de Geus C, Holroyd B, Russell AS. Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med. 2001;161:1309-12. [PMID: 11371259] CrossrefMedlineGoogle Scholar8. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001;345:941-7. [PMID: 11575285] CrossrefMedlineGoogle Scholar9. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, . Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333-40. [PMID: 11172164] CrossrefMedlineGoogle Scholar10. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, . Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-41. [PMID: 11346808] CrossrefMedlineGoogle Scholar11. Nystrm L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydn S, . Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993;341:973-8. [PMID: 8096941] CrossrefMedlineGoogle Scholar12. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347-60. [PMID: 12204020] LinkGoogle Scholar13. Blanck HM, Khan LK, Serdula MK. Use of nonprescription weight loss products: results from a multistate survey. JAMA. 2001;286:930-5. [PMID: 11509057] CrossrefMedlineGoogle Scholar14. Dube SR, Ande RF, Felitti VJ, Chapman DP, Williamson DF, Giles WH. Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study. JAMA. 2001;286:3089-96. [PMID: 11754674] CrossrefMedlineGoogle Scholar15. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001;345:1007-13. [PMID: 11586952] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Karen M. Freund, MD, MPH; Nancy C. Dolan, MD; Heidi D. Nelson, MD, MPHAffiliations: From Boston University Medical Center, Boston, Massachusetts; Feinberg School of Medicine, Northwestern University Medical School, Chicago, Illinois; and Oregon Health & Science University, Portland, Oregon.Corresponding Author: Karen M. Freund, MD, Women's Health Unit, Evans Department of Medicine, and the Center for Excellence in Women's Health, Boston University Medical Center, 720 Harrison Avenue, Suite 1108, Boston, MA 02118; e-mail, karen.[email protected]org.Current Author Addresses: Dr. Freund: Women's Health Unit, Evans Department of Medicine, and the Center for Excellence in Women's Health, Boston University Medical Center, 720 Harrison Avenue, Suite 1108, Boston, MA 02118.Dr. Dolan: Division of General Internal Medicine, Feinberg School of Medicine, Northwestern University, 675 North St. Clair, Suite 18-200, Chicago, Il 60611.Dr. Nelson: Oregon Health & Science University, 3181 SW Sam Jackson Park Road, MC-BICC, 504, Portland, OR 97201. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byImmunohistochemical expression and prognostic relevance of Bmi-1, a stem cell factor, in epithelial ovarian cancerCHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survivalIntensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma 21 January 2003Volume 138, Issue 2Page: 119-127KeywordsBone mineral densityBreast cancerEstrogensHuman papillomavirusIntrauterine devicesMortalityObstetrics and gynecologyOsteoporosisRelative risk ePublished: 21 January 2003 Issue Published: 21 January 2003 Copyright & PermissionsCopyright © 2003 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...